11 Cheap Pharmaceutical Stocks to Buy Now

Page 2 of 10

9. Biogen Inc. (NASDAQ:BIIB)

Forward P/E: 8.05

Number of Hedge Fund Holders: 52

Biogen Inc. (NASDAQ:BIIB) is one of the top cheap pharmaceutical stocks to buy now. BofA lowered the firm’s price target on Biogen Inc. (NASDAQ:BIIB) to $142 from $143 on August 1, keeping a Neutral rating on the shares.

The firm told investors that Biogen Inc.’s (NASDAQ:BIIB) 2025 estimates are “slightly higher” after a “big beat and raise” in fiscal Q2 2025. However, it added that the company trimmed its price target, rolling its valuation to its 2026 EPS estimate.

BofA further stated that while Biogen Inc. (NASDAQ:BIIB) is “admittedly one of the cheaper names in large-cap biopharma,” the company is struggling to see a compelling “buy thesis” as the growth outlook over the next few years “remains lackluster.”

Biogen Inc. (NASDAQ:BIIB) is a global biopharmaceutical company that discovers, develops, and delivers advanced therapies for serious diseases worldwide.

Its medicine portfolio treats multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS).

Page 2 of 10